CoChat

Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning

Open access
Cao, Chenghui, Liu, Wenwu, Guo, Xin, Weng, Shuwei, Chen, Yang, Luo, Yonghong, Wang, Shuai, Zhu, Botao, Liu, Yuxuan, Peng, Daoquan · 2024 · Frontiers in Immunology

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Abstract

Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a highly prevalent liver disease globally, with a significant risk of progressing to cirrhosis and even liver cancer. Efferocytosis, a process implicated in a broad spectrum of chronic inflammatory disorders, has been reported to be associated with the pathogenesis of MASH; however, its precise role remains obscure. Thus, we aimed to identify and validate efferocytosis linked signatures for detection of MASH. Methods: We retrieved gene expression patterns of MASH from the GEO database and then focused on assessing the differential expression of efferocytosis-related genes (EFRGs) between MASH and control groups. This analysis was followed by a series of in-depth investigations, including protein–protein interaction (PPI), correlation analysis, and functional enrichment analysis, to uncover the molecular interactions and pathways at play. To screen for biomarkers for diagnosis, we applied machine learning algorithm to identify hub genes and constructed a clinical predictive model. Additionally, we conducted immune infiltration and single-cell transcriptome analyses in both MASH and control samples, providing insights into the immune cell landscape and cellular heterogeneity in these conditions. Results: This research pinpointed 39 genes exhibiting a robust correlation with efferocytosis in MASH. Among these, five potential diagnostic biomarkers— TREM2, TIMD4, STAB1, C1QC, and DYNLT1 —were screened using two distinct machine learning models. Subsequent external validation and animal experimentation validated the upregulation of TREM2 and downregulation of TIMD4 in MASH samples. Notably, both TREM2 and TIMD4 demonstrated area under the curve (AUC) values exceeding 0.9, underscoring their significant potential in facilitating the diagnosis of MASH. Conclusion: Our study comprehensively elucidated the relationship between MASH and efferocytosis, constructing a favorable diagnostic model. Furthermore, we identified potential therapeutic targets for MASH treatment and offered novel insights into unraveling the underlying mechanisms of this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2024.1460431

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart illustrating the present study design. 5 hub genes (TREM2, TIMD4, STAB1, C1QC and DYNLT1) were identified by two machine learning algorithms.
Figure 1 Flowchart illustrating the present study design. 5 hub genes (TREM2, TIMD4, STAB1, C1QC and DYNLT1) were identified by two machine learning algorithms.CC BY · PubMed Central
Figure 2 Identification of differentially expressed EFRGs. (A) PCA showed significant differences between the MASH and control liver samples. (B) Volcano plot showed the DEGs between MASH and control groups, and the top eight genes with the most significant fold changes was pointed. (C) Venn diagram showed the intersection of genes between DEGs and EFRGs. (D) Heatmaps showed the 39 intersected EFRGs. DEGs, differential expression genes; EFRGs, efferocytosis-related genes.
Figure 2 Identification of differentially expressed EFRGs. (A) PCA showed significant differences between the MASH and control liver samples. (B) Volcano plot showed the DEGs between MASH and control groups, and the top eight genes with the most significant fold changes was pointed. (C) Venn diagram showed the intersection of genes between DEGs and EFRGs. (D) Heatmaps showed the 39 intersected EFRGs. DEGs, differential expression genes; EFRGs, efferocytosis-related genes.CC BY · PubMed Central
Figure 3 Functional enrichment analysis of differentially expressed EFRGs. (A) Butterfly diagram of the GO enrichment analysis of 39 up- and down-regulated EFRGs, Biological process (BP). (B) Butterfly diagram of the GO enrichment analysis of 39 up- and down-regulated EFRGs, Molecular function (MF). (C) Bubble diagrams of the DO enrichment analysis of 39 differentially expressed EFRGs. (D) The KEGG enrichment analysis plot displays the signaling pathways most closely related to the 39 intersecting EFRGs. (E) The KEGG enrichment analysis circular plot depicts a network of gene-pathway relationships.
Figure 3 Functional enrichment analysis of differentially expressed EFRGs. (A) Butterfly diagram of the GO enrichment analysis of 39 up- and down-regulated EFRGs, Biological process (BP). (B) Butterfly diagram of the GO enrichment analysis of 39 up- and down-regulated EFRGs, Molecular function (MF). (C) Bubble diagrams of the DO enrichment analysis of 39 differentially expressed EFRGs. (D) The KEGG enrichment analysis plot displays the signaling pathways most closely related to the 39 intersecting EFRGs. (E) The KEGG enrichment analysis circular plot depicts a network of gene-pathway relationships.CC BY · PubMed Central
Figure 4 Identification of hub genes using machine learning. (A) The accuracy and (B) the error of the feature selection for the SVM-RFE algorithm. 13 genes were pinpointed. (C, D) 7 genes were identified through the LASSO regression algorithm. (E) The Venn diagram showed the overlap of hub genes between SVM-RFE and LASSO algorithms.
Figure 4 Identification of hub genes using machine learning. (A) The accuracy and (B) the error of the feature selection for the SVM-RFE algorithm. 13 genes were pinpointed. (C, D) 7 genes were identified through the LASSO regression algorithm. (E) The Venn diagram showed the overlap of hub genes between SVM-RFE and LASSO algorithms.CC BY · PubMed Central
Figure 5 GSEA analysis of five marker genes. The KEGG pathway enrichment analysis of (A) TREM2, (B) TIMD4, (C) STAB1, (D) C1QC and (E) DYNLT1 were conducted by GSEA enrichment method, and the five pathways with the highest and lowest enrichment scores are visualized according to the arrangement of enrichment scores.
Figure 5 GSEA analysis of five marker genes. The KEGG pathway enrichment analysis of (A) TREM2, (B) TIMD4, (C) STAB1, (D) C1QC and (E) DYNLT1 were conducted by GSEA enrichment method, and the five pathways with the highest and lowest enrichment scores are visualized according to the arrangement of enrichment scores.CC BY · PubMed Central
Figure 6 PPI and TF-miRNA-mRNA regulatory network. (A) 39 intersected genes of MASH and efferocytosis were explored within the PPI network. (B) TF-miRNA-mRNA regulatory network of the five hub genes.
Figure 6 PPI and TF-miRNA-mRNA regulatory network. (A) 39 intersected genes of MASH and efferocytosis were explored within the PPI network. (B) TF-miRNA-mRNA regulatory network of the five hub genes.CC BY · PubMed Central
Figure 7 Immune Infiltration and scRNA-Seq analysis between MASH and control groups. (A) Boxplots showed immune infiltration differences between MASH and control samples. 7/22 immune cells significantly differ in MASH and controls. (B) The relationship between varied immune cell infiltration and five marker genes is depicted, with red indicating positive correlation and blue indicating negative correlation. (C) t-SNE plot showed the 10 identified cell clusters of the scRNA-Seq dataset GSE128334. (D) Violin plot demonstrated the five hub genes expression level in different cell clusters between MASH and control groups. ns indicates not significant, * indicates P<0.05, ** indicates P<0.01, *** indicates P<0.001.
Figure 7 Immune Infiltration and scRNA-Seq analysis between MASH and control groups. (A) Boxplots showed immune infiltration differences between MASH and control samples. 7/22 immune cells significantly differ in MASH and controls. (B) The relationship between varied immune cell infiltration and five marker genes is depicted, with red indicating positive correlation and blue indicating negative correlation. (C) t-SNE plot showed the 10 identified cell clusters of the scRNA-Seq dataset GSE128334. (D) Violin plot demonstrated the five hub genes expression level in different cell clusters between MASH and control groups. ns indicates not significant, * indicates P<0.05, ** indicates P<0.01, *** indicates P<0.001.CC BY · PubMed Central
Figure 8 Validation of marker gene expression. (A) The ROC results of five marker genes in GSE246221. The AUC value of TREM2, TIMD4, STAB1, C1QC and DYNLT1 was 0.955, 0.966, 0.489, 0.568, 0,716 respectively. (B) Nomogram for the diagnosis of MASH based on the hub genes. (C) Boxplots indicating the five differentially expressed EFRGs between MASH and control samples in GSE126848. (D) Boxplots indicating the five differentially expressed EFRGs between MASH and control samples in GSE246221.
Figure 8 Validation of marker gene expression. (A) The ROC results of five marker genes in GSE246221. The AUC value of TREM2, TIMD4, STAB1, C1QC and DYNLT1 was 0.955, 0.966, 0.489, 0.568, 0,716 respectively. (B) Nomogram for the diagnosis of MASH based on the hub genes. (C) Boxplots indicating the five differentially expressed EFRGs between MASH and control samples in GSE126848. (D) Boxplots indicating the five differentially expressed EFRGs between MASH and control samples in GSE246221.CC BY · PubMed Central
Figure 9 Construction of MASH mice model and validation of hub genes. (A) The HE and Oil Red staining in Control and MASH mice. Scale bar, 100 μm. (B, C) serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level mice model. (D) Blood glucose levels after 6 h of fasting. (E, F) Relative mRNA levels of Trem2 and Timd4 in MASH and Control mice, standardized by Gapdh. (G) Immunohistochemical staining of TREM2 and TIMD4 in MASH and Control mice. (H-J) Relative protein level of TREM2 and TIMD4 in MASH and Control mice, standardized by β-tubulin. ** indicates P<0.01, *** indicates P<0.001, **** indicates P<0.0001.
Figure 9 Construction of MASH mice model and validation of hub genes. (A) The HE and Oil Red staining in Control and MASH mice. Scale bar, 100 μm. (B, C) serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level mice model. (D) Blood glucose levels after 6 h of fasting. (E, F) Relative mRNA levels of Trem2 and Timd4 in MASH and Control mice, standardized by Gapdh. (G) Immunohistochemical staining of TREM2 and TIMD4 in MASH and Control mice. (H-J) Relative protein level of TREM2 and TIMD4 in MASH and Control mice, standardized by β-tubulin. ** indicates P<0.01, *** indicates P<0.001, **** indicates P<0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 16

Metadata

Authors
Cao, C., Liu, W., Guo, X., Weng, S., Chen, Y., Luo, Y., Wang, S., Zhu, B., Liu, Y., & Peng, D.
Affiliations
Central South University (CN)
Corresponding author
Peng, Daoquan
Venue
Frontiers in Immunology
Published
2024-10-21
Volume
15
Pages
1460431-1460431
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4403583736
Cited by
16
References
72
Citations by year
2026: 9 · 2025: 7
FWCI
4.85
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81870336, 81600359)
  • Xiangya Hospital, Central South University
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
nonalcoholic steatohepatitis, efferocytosis, diagnostic biomarkers, TREM2, TIMD4, hub genes, immune cell infiltration, single-cell transcriptome, liver disease diagnosis, therapeutic target
MeSH terms
Machine Learning, Efferocytosis, Animals, Fatty Liver, Humans, Phagocytosis, Biomarkers, Computational Biology, Gene Expression Profiling, Transcriptome, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning. https://app.cochat.ai/papers/10.3389/fimmu.2024.1460431
The paper
Cao, C., Liu, W., Guo, X., Weng, S., Chen, Y., Luo, Y., Wang, S., Zhu, B., Liu, Y., & Peng, D. (2024). Identification and validation of efferocytosis-related biomarkers for the diagnosis of metabolic dysfunction-associated steatohepatitis based on bioinformatics analysis and machine learning. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2024.1460431

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.